/Companies

HeartFlow Holding

NASDAQ: HTFL

Mountain View, US · Founded 2021 · Delaware corporation · 1 known investors

Find your way into HeartFlow Holding

Each arrow is one introduction. Sign up to fill in the first one.

10 people can intro you to John

Ask Michael Y. Mashaal to introduce you to John Farquhar

You →Michael · together at HeartFlow →John

Sign up to find every way you can get introduced to HeartFlow Holding

  • Your email: who you already know at HeartFlow Holding, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the HeartFlow Holding team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

HeartFlow develops AI-powered software that analyzes coronary CT scans to diagnose and assess coronary artery disease by quantifying blood flow, plaque volume, and plaque composition for cardiologists and radiologists. The platform has been applied to over 600,000 patients and is used across more than 1,400 accounts in the United States.

Founders & leadership

HeartFlow Holding was founded in 2021 by Charles Taylor.

CT
Charles TaylorFounder
JFJohn Farquhar
John FarquharExecutiveJohn Farquhar is president and CEO of HeartFlow, an AI software company that analyzes coronary CT scans to assess coronary artery disease. He previously held leadership roles in cardiovascular and diabetes divisions at Medtronic, and holds a bachelor's degree from Duke University and an MBA from Northwestern University's Kellogg School of Management.
VV
Vikram VergheseExecutive
JCJohn C.M. Farquhar
John C.M. FarquharPresident, Chief Executive Officer & DirectorJohn C.M. Farquhar holds an MBA from Northwestern University's Kellogg School of Management and a bachelor's degree from Duke University. He previously held leadership roles in cardiovascular and diabetes divisions at Medtronic before becoming president and CEO of HeartFlow.
CDCampbell D.K. Rogers
Campbell D.K. RogersChief Medical OfficerChief Medical Officer at HeartFlow
MT
Monica TelladoNamed on SEC filing

Board

JL
Jeff LightcapBoard director
CTCasey Tansey
Casey TanseyBoard directorGeneral Partner at US Venture Partners
ND
Nicholas DowningBoard director
LS
Lonnie SmithBoard director
TB
Tim BarabeBoard director
JC
Julie CullivanBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$314.2M disclosed across 3 rounds · 2023–2025

▶$50MraisedApr 2025 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff LightcapDirector
  • Casey TanseyDirector
  • Charles TaylorDirector
  • John FarquharExecutive Officer, Director
  • Nicholas DowningDirector
  • Lonnie SmithDirector
  • Tim BarabeDirector
  • Vikram VergheseExecutive Officer
  • Julie CullivanDirector
  • William WeldonDirector
  • Wayne RileyDirector
Offering amount
$50M
Amount sold
$50M
First sale
Mar 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$48.4MraisedFeb 2025 · 79 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Vikram VergheseExecutive Officer
  • Tim BarabeDirector
  • Nicholas DowningDirector
  • John FarquharExecutive Officer, Director
  • Julie CullivanDirector
  • Casey TanseyDirector
  • Charles TaylorDirector
  • Wayne RileyDirector
  • William WeldonDirector
  • Lonnie SmithDirector
  • Jeff LightcapDirector
Offering amount
$75M
Amount sold
$48.4M
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$215.9MraisedApr 2023 · 40 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Wayne RileyDirector
  • Casey TanseyDirector
  • Monica TelladoExecutive Officer
  • John FarquharExecutive Officer, Director
  • Julie CullivanDirector
  • William WeldonDirector
  • Charles TaylorExecutive Officer, Director
  • Nicholas DowningDirector
  • Jeff LightcapDirector
  • Lonnie SmithDirector
  • Tim BarabeDirector
Offering amount
$215.9M
Amount sold
$215.9M
Sales commissions
$3.5M
Proceeds to insiders
$855.1K
Placement agents
J.P. MORGAN SECURITIES LLC
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does HeartFlow Holding do?
HeartFlow develops AI-powered software that analyzes coronary CT scans to diagnose and assess coronary artery disease by quantifying blood flow, plaque volume, and plaque composition for cardiologists and radiologists. The platform has been applied to over 600,000 patients and is used across more than 1,400 accounts in the United States.
Who founded HeartFlow Holding?
HeartFlow Holding was founded by Charles Taylor in 2021.
Who are HeartFlow Holding's investors?
HeartFlow Holding's investors include US Venture Partners.
How much funding has HeartFlow Holding raised?
HeartFlow Holding has disclosed $314.2M raised across 3 rounds.
Where is HeartFlow Holding headquartered?
HeartFlow Holding is headquartered in Mountain View, US.